ID
41530
Description
Study ID: 111476 Clinical Study ID: 111476 Study Title: An open, single-arm trial to assess the clinical activity of recMAGE-A3 + AS15 in patients with unresectable MAGE-A3-positive metastatic cutaneous melanoma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00942162 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Antigen-Specific Cancer Immunotherapeutic Study Indication: Melanoma
Keywords
Versions (2)
- 9/21/20 9/21/20 -
- 11/2/20 11/2/20 -
Copyright Holder
GlaxoSmithKline
Uploaded on
November 2, 2020
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Clinical activity of recMAGE-A3 + AS15 in patients with metastatic cutaneous melanoma NCT00942162
Chronic and concomitant medication; Concomitant vaccination (Report Final and Annex Report 2 Final)
Description
Chronic and concomitant medication
Alias
- UMLS CUI-1
- C2347852
- UMLS CUI-2
- C0013227
- UMLS CUI-3
- C0205191
Description
Have any chronic or concomitant medications/treatments (other than anti-cancer treatment) been administered?
Data type
boolean
Alias
- UMLS CUI [1]
- C2347852
- UMLS CUI [2,1]
- C0013227
- UMLS CUI [2,2]
- C0205191
- UMLS CUI [3]
- C0920425
Description
Chronic and concomitant medication
Alias
- UMLS CUI-1
- C2347852
- UMLS CUI-2
- C0013227
- UMLS CUI-3
- C0205191
Description
Trade/ Generic Name
Data type
text
Alias
- UMLS CUI [1]
- C0013227
Description
Medical Indication
Data type
text
Alias
- UMLS CUI [1,1]
- C3146298
- UMLS CUI [1,2]
- C0013227
Description
Medications/ Treatments status
Data type
integer
Alias
- UMLS CUI [1]
- C0013227
- UMLS CUI [2]
- C0087111
- UMLS CUI [3]
- C0449438
Description
Total daily dose
Data type
text
Alias
- UMLS CUI [1,1]
- C2348070
- UMLS CUI [1,2]
- C0439810
Description
Administration route
Data type
text
Alias
- UMLS CUI [1]
- C0013153
Description
Medication Start date
Data type
date
Alias
- UMLS CUI [1]
- C2826734
Description
Medication end date
Data type
date
Alias
- UMLS CUI [1]
- C2826744
Description
Medication continuing at end of study
Data type
boolean
Alias
- UMLS CUI [1]
- C1553904
Description
Concomitant Vaccination
Alias
- UMLS CUI-1
- C0042196
- UMLS CUI-2
- C2347852
Description
Concomitant Vaccination
Alias
- UMLS CUI-1
- C0042196
- UMLS CUI-2
- C2347852
Description
Trade / (Generic) Name
Data type
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C2360065
Description
Vaccine administration route
Data type
text
Alias
- UMLS CUI [1,1]
- C0013153
- UMLS CUI [1,2]
- C0042210
Description
Vaccine administration date
Data type
date
Alias
- UMLS CUI [1,1]
- C2368628
- UMLS CUI [1,2]
- C0011008
Similar models
Chronic and concomitant medication; Concomitant vaccination (Report Final and Annex Report 2 Final)
C0013227 (UMLS CUI-2)
C0205191 (UMLS CUI-3)
C0013227 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0920425 (UMLS CUI [3])
C0013227 (UMLS CUI-2)
C0205191 (UMLS CUI-3)
C0013227 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2])
C0449438 (UMLS CUI [3])
C0439810 (UMLS CUI [1,2])
C2347852 (UMLS CUI-2)
C2348563 (UMLS CUI [1,2])
C2347852 (UMLS CUI-2)
C2360065 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
No comments